These results indicate that FGFRL1 upregulation and altered cellular compartmentalization contribute to PCa development and progression, and the nuclear FGFRL1 could serve as a prognostic marker for PCa patients. This evidence concerns the gene FGFRL1 and posterior cortical atrophy.